CBFA2T3::GLIS2 fusions have recently been an important clinical problem due to poor prognostic factors they are associated with and still insufficient knowledge regarding clinical solutions, since they represent a small subgroup in the overall population of pediatric patients with AML. Here, CBFA2T3 is linked to acute myeloid leukemia.